The emerging therapy of the medication represents a significant breakthrough in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide594237.ivasdesign.com/63246661/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment